Defibrillators Market is expected to garner $15,610 million by 2022 with a CAGR of 6.5% during the forecast period 2014-2022. Defibrillators are devices used to deliver therapeutic shock to a patient’s heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure encompasses delivery of an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse.
Get Sample PDF of This Report@ https://www.alliedmarketresearch.com/request-sample/1434
The increase in adoption of technologically advanced defibrillators, growing demand for quality medical care, high incidences of SCA, and cardiovascular diseases are the drivers of growth. In addition, the increasing focus of public & private organizations and key market players on public access defibrillators and an increase in number of training & awareness programs across the globe are a few more factors driving the growth of this industry.
The report provides a comprehensive analysis of the key players operating in the world defibrillators market, such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.
Access Full Summary of the Report@ https://www.alliedmarketresearch.com/defibrillator-market
DEFIBRILLATORS MARKET SEGMENTS
- Implantable Defibrillators
- Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
- Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
- Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
- External defibrillators
- Manual External Defibrillator
- Automated External Defibrillator (AEDs),
- Wearable Cardioverter Defibrillator (WCDs).
By End User
- Public Access market
- Alternate Care Market